1 May – 31 Oct 2017
Companies are listed in alphabetical order
1 May – 31 October 2017
- A. Menarini Australia Pty Ltd
153k - AbbVie Pty Limited 182k
- Actelion Pharmaceuticals Australia Pty Ltd 66k
- Amgen Australia Pty Ltd 121k
- Astellas Pharma 279k
- AstraZeneca Pty Ltd 222k
- Bayer Australia Limited 109k
- Besins Healthcare 381k
- Biogen Australia Pty Ltd 78k
- Bristol-Myers Squibb Australia Pty Ltd 212k
- Boehringer Ingelheim Pty Ltd 61k
- Celgene Pty Ltd 99k
- CSL Behring 76k
- Eisai Australia Pty Ltd 191k
- Eli Lilly Australia Pty Ltd 166k
- Gilead Sciences Pty Ltd 95k
- GlaxoSmithKline Australia Pty Ltd 257k
- iNova Pharmaceuticals 349k
- Ipsen Pty Ltd 59k
- Janssen 397k
- Merck Serono Australia Pty Ltd 41k
- MSD Australia 82k
- Norgine Pty Limited 69k
- Novartis Pharmaceuticals Australia Pty Ltd 99k
- Novo Nordisk Pharmaceuticals Pty Ltd 123k
- Pfizer Australia Pty Ltd 425k
- Roche Products Pty Ltd 325k
- Sanofi 165k
- Seqirus 234k
- Shire Australia Pty Limited 206k
- Takeda Pharmaceuticals Australia Pty Ltd 195k
- UCB Australia Pty Ltd 57k
- Vifor Pharma 46k